𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Feasibility of placebo-controlled clinical trials of antipsychotic compounds in Europe

✍ Scribed by Wolfgang W. Fleischhacker; Tom Burns; European Group for Research in Schizophrenia


Publisher
Springer
Year
2002
Tongue
English
Weight
22 KB
Volume
162
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Ethics of placebo-controlled trials in d
✍ J. Guy Edwards πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 189 KB

## Ethics of placebo-controlled trials in depression Some believe that introducing a placebo control into an antidepressant drug trial means that ill patients are being unnecessarily deprived of treatment. As a result, many clinicians and ethical committees are opposed to the use of such trial met

The clinical characteristics of schizoph
✍ J. T. Bowen; T. R. E. Barnes πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 744 KB

Sixty-seven patients meeting DSM-III-R criteria for schizophrenia who had been eligible for a placebo controlled trial of an antipsychotic preparation were followed up at 9 months to examine whether a variety ofsocio-demographic, illness, treatment and compliance variables were associated with conse

Mirtazapine add-on therapy in the treatm
✍ Michael Berk; Clarissa S. Gama; Suresh Sundram; Harry Hustig; Les Koopowitz; Rus πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 1 views

## Abstract ## Objective Schizophrenia is a multifaceted illness with positive, negative and cognitive symptom domains. Standard treatments often focus on positive symptoms and may not adequately relieve other symptoms. Previous studies have suggested a role for mirtazapine in schizophrenia, parti